In APOE*3 Leiden mice, another hyperlipidemic model sensitive to hepatic steatosis, AMP-DNM treatment corrected liver accumulation of fat and reduced inflammation in a similar fashion to what was observed with LDLR(−/−) mice. Here, APOE is linked to Hepatic steatosis.